Skip to main content

Table 1 Sequence of the primers used

From: Oligoclonality in the Human CD8+ T Cell Repertoire in Normal Subjects and Monozygotic Twins: Implications for Studies of Infectious and Autoimmune Diseases

Primer

Sequence

Position

Reaction Set

BV1

5′-CAACAGTTCCCTGACTTGCAC-3′

84

A

BV2

5′-TCAACCATGCAAGCCTGACCT-3′

86

B

BV3

5′-TCTAGAGAGAAGAAGGAGCGC-3′

86

C

BV4

5′-CATATGAGAGTGGATTTGTCATT-3′

122

B

BV5S1

5′-TTCAGTGAGACACAGAGAAAC-3′

135

D

BV5S2

5′-CCTAACTATAGCTCTGAGCTG-3′

75

D

BV6

5′-AGGCCTGAGGGATCCGTCTC-3′

81

E

BV7

5′-CTGAATGCCCCAACAGCTCTC-3′

86

F

BV8

5′-TACTTTAACAACAACGTTCCG-3′

144

B

BV9

5′-AAATCTCCAGACAAAGCTCAC-3′

84

G

BV10

5′-CAAAAACTCATCCTGTACCTT-3′

76

L

BV11

5′-ACAGTCTCCAGAATAAGGACG-3′

90

H

BV12

5′-GACAAAGGAGAAGTCTCAGAT-3′

117

H

BV13S1

5′-GACCAAGGAGAAGTCCCCAAT-3′

117

C

BV13S2

5′-GTTGGTGAGGGTACAACTGCC-3′

135

I

BV14

5′-TCTCGAAAAGAGAAGAGGAAT-3′

84

J

BV15

5′-GTCTCTCGACAGGCACAGGCT-3′

87

I

BV16

5′-GAGTCTAAACAGGATGAGTCC-3′

132

G

BV17

5′-CACAGATAGTAAATGACTTTCAG-3′

137

J

BV18

5′-GAGTCAGGAATGCCAAAGGAA-3′

117

A

BV19

5′-CCCCAAGAACGCACCCTGC-3′

79

K

BV20

5′-TCTGAGGTGCCCCAGAATCTC-3′

111

E

BV21

5′-GATATGAGAATGAGGAAGCAG-3′

143

L

BV22

5′-CAGAGAAGTCTGAAATATTCGA-′

122

F

BV23

5′-TCATTTCGTTTTATGAAAAGATGC-3′

146

A

BV24

5′-AAAGATTTTAACAATGAAGCAGAC-3′

129

K

CB-14

5′-CTCAGCTCCACGTG-3′

  

CB-R

5′-CTTCTGATGGCTCAAACAC-3′

  

BJ1S1

5′-AACTGTGAGTCTGGTGCCTT-3′

  

BJ1S2

5′-ACGGTTAACCTGGTCCCCGA-3′

  

BJ1S3

5′-CTCTACAACAGTGAGCCAAC-3′

  

BJ1S4

5′-GACAGAGAGCTGGGTTCCAC-3′

  

BJ1S5

5′-TGGAGAGTCGAGTCCCATCA-3′

  

BJ1S6

5′-TGAGCCTGGTCCCATTCCCA-3′

  

BJ2S1

5′-CCTCTAGCACGGTGAGCCGT-3′

  

BJ2S2

5′-TACGGTCAGCCTAGAGCCTT-3′

  

BJ2S3

5′-CTGTCAGCCGGGTGCCTGGG-3′

  

BJ2S4

5′-CTGAGAGCCGGGTCCCGGCG-3′

  

BJ2S5

5′-CCTCGAGCACCAGGAGCCGC-3′

  

BJ2S6

5′-CCTGCTGCCGGCCCCGAAAG-3′

  

BJ2S7

5′-TGACCGTGAGCCTGGTGCCC-3′

 Â